Vimal Patel

Vimal Patel is an experienced professional in the field of Chemistry, Manufacturing, and Controls (CMC) with a strong background in biopharmaceutical development. Currently serving as the Vice President of CMC at Radiopharm Theranostics, Vimal has held key leadership roles at Orum Therapeutics and Daiichi Sankyo, Inc. Prior to these positions, substantial contributions were made at Actinium Pharmaceuticals and Pfizer, focusing on purification processes for antibody-drug conjugates (ADCs) and technology transfer. Vimal's extensive experience also includes significant roles at Progenics Pharmaceuticals and SibTech, Inc., where expertise in protein purification, drug delivery systems, and analytical methodologies was developed. An academic foundation in biotechnology and chemical engineering supports a robust career in therapeutic protein development.